Ferrokinetic studies with
59Fe-labelled dextrin citrato-iron (III) complex (Ferricon) were performed in anemic rabbits due to bleeding and acute liver damaged rabbits due to carbon tetrachloride administration. In the anemic rabbits, labelled Ferricon was rapidly disappeared from the circulating plasma, red blood cell utilization of
59Fe increased than normal control. On the other hand in the liver damaged rabbits, the disappearance rate was slow and
59Fe utilization into hemopoiesis was decreased.
Ferricon was administered intravenously to 8 cases of iron deficiency anemia in gastroenteropathy or after gastrectomy. The red blood cells, hemoglobin and hematocrit levels were increased after reticulocyte crisis in all cases. Ferrokinetics with
59Fe labelled Ferricon was studied on a case of iron deficiency anemia after gastrectomy, the iron was incorporated relatively slow and continuously into red blood cells. These results showed that Ferricon had a continuous effect for hemopoiesis and little side effects. The indication for clinical use and other favorable effects were also discussed.
View full abstract